Mycosis fungoides

Exam relevance: in 6 of more than 50 board exam reports · rank 24

Synonyms
kutanes T-Zell-Lymphom, CTCL, cutaneous T-cell lymphoma
Specialty
Dermatology · Skin tumours
Images
Clinical 3 · Histology 1
In the app
7 flashcards
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (4)
  2. Definition
  3. Clinical features
  4. Diagnosis
  5. Differential diagnoses
  6. Treatment principles
  7. Keep learning in the app
  8. References (selection)
  9. Cross-references

Images (4)

Mycosis fungoides – clinical photo: ill-defined, slightly infiltrated erythematosquamous lesion with fine scaling at the knee
ill-defined, slightly infiltrated erythematosquamous lesion with fine scaling at the kneeWikindrea, “Mycosis Fungoides Before Sun and Cartamo”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
Mycosis fungoides – clinical photo: Back: scaly patches and thin plaques, plus a crusted, eroded tumour and a smooth pink nodule
Back: scaly patches and thin plaques, plus a crusted, eroded tumour and a smooth pink noduleZaminski D, Taiwo D, Meehan SA et al. (JAAD Case Rep 2024), CC BY 4.0, via PubMed Central (PMC11539343) – figure 1 · CC BY 4.0 · Source
Mycosis fungoides – clinical photo: Poikilodermatous variant: reticulate red-violaceous macules with telangiectasia and fine atrophy (detail, lower abdomen)
Poikilodermatous variant: reticulate red-violaceous macules with telangiectasia and fine atrophy (detail, lower abdomen)Mihalceanu S, Toberer F (Dermatologie 2025), CC BY 4.0, via PubMed Central (PMC12589270) – figure 1, cropped · CC BY 4.0 · Source
Mycosis fungoides – histology (H&E): epidermotropism of atypical lymphocytes with clear halo, small Pautrier microabscesses, minimal spongiosisHistology
histology (H&E): epidermotropism of atypical lymphocytes with clear halo, small Pautrier microabscesses, minimal spongiosisLWozniak&KWZielinski, “SkinTumors-P8261373”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
1 / 4

Definition

Definition & Epidemiology

  • Mycosis fungoides (MF) = most common cutaneous T-cell lymphoma (CTCL), originating from CD4-positive helper memory T-cells with skin tropism.
  • Sézary syndrome (SS) = leukemic variant with erythroderma + circulating atypical T-cells + generalized lymphadenopathy.
  • Incidence of MF ~ 0.5 / 100,000 / year; mostly 50–60 years of age; M:F ≈ 2:1.

Clinical features

Clinical Presentation by Stage

  • Patch: reddish-brown, non-infiltrated macules with fine lamellar scaling, often on buttocks / trunk
  • Plaque: infiltrated erythematous plaques, sharply demarcated
  • Stage IA / IB is defined not by patch versus plaque but by the body surface area involved: IA < 10 % BSA (T1), IB ≥ 10 % BSA (T2)
  • Tumor (IIB): exophytic nodules / tumors, often ulcerated
  • Erythroderma (III): > 80 % BSA, pruritus, "L'homme rouge"
  • Sézary (IV): + atypical circulating cells, lymphadenopathy

Sézary Syndrome

  • Triad: Erythroderma + generalized lymphadenopathy + atypical circulating Sézary cells.
  • Excessive pruritus ("Sézary pruritus") — scratch-induced lichenification.
  • Folliculotropic variant with alopecia + comedones + mucinosis.

Diagnosis

Diagnostics

Histology

  • Characteristic but not obligatory correlate Pautrier microabscesses — intraepidermal CD4+ T-cell aggregates without significant spongiosis.
  • Epidermotropism of atypical T-cells without spongiosis (DD to eczema).
  • In advanced stages, dense band-like infiltrate in the upper dermis.

Immunohistochemistry + Clonality

  • CD3+/CD4+/CD45RO+ T-helper cells, partial CD7 loss.
  • TCR gene rearrangement PCR (T-cell clonality) — supports diagnosis, not solely diagnostic.

Flow Cytometry (peripheral blood)

  • Sézary cell phenotype CD4+/CD7−/CD26− — atypical T-cells with CD7 and CD26 loss.
  • Sézary diagnosis: ≥ 1000 Sézary cells/µl OR CD4:CD8 ratio > 10 OR ≥ 40 % CD4+/CD7 loss.

Tumor Burden Markers

  • Tumor burden markers LDH + β2-microglobulin — as a surrogate for tumor mass.
  • Staging: TNMB system (Olsen 2007), mSWAT score (BSA × lesion severity).

Differential diagnoses

Image credits for the thumbnails
  • Seborrhoeic dermatitis: Roymishali, “Seborrhoeic dermatitis highres”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
  • Atopic dermatitis (atopic eczema): Eisfelder, “Atopic dermatitis child”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
  • Folliculitis decalvans: Mohammad2018, “Foliculitis declavane new photo to avoid wrong diagnosis”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
  • Psoriasis vulgaris (plaque psoriasis): MediaJet, “An Arm Covered With Plaque Type Psoriasis”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
  • Primary cutaneous anaplastic large cell lymphoma (pcALCL): Varela A, Sepúlveda S, Evans NE et al. (Cureus 2026), CC BY 4.0, via PubMed Central (PMC13061649) · CC BY 4.0 · Source

Treatment principles

  • Treatment is stage-dependent and in most cases aims at disease control rather than cure.
  • In early stages, skin-directed therapies predominate: topical glucocorticoids or cytostatics, phototherapy (narrowband UVB for patches, PUVA for plaques) and local radiotherapy.
  • Advanced stages receive total skin electron beam therapy or systemic treatments such as retinoids, interferons, antibodies or chemotherapy, and extracorporeal photopheresis in Sézary syndrome.
  • Planning is interdisciplinary; in selected patients, allogeneic stem cell transplantation can be curative.

Guideline: AWMF guideline register (no. 032-027)

Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.

Keep learning in the app

In the DermaFuchs app you can learn Mycosis fungoides with flashcards, exam questions and spot-the-diagnosis – free, in your browser or as an app.

Test yourself: Spot-diagnosis quiz with real cases →

In the app: 7 flashcards

Open in browser  Download on the App Store

References (selection)

  1. AWMF S2k Kutane Lymphome 2021

Cross-references

Keep learning: test yourself

One question from the DermaFuchs app on Mycosis fungoides – tap an answer.

Question 1 of 1

What is the Sézary cell phenotype in Mycosis Fungoides and Sézary Syndrome?

Answer

Correct: CD4+/CD7−/CD26−. Sézary cells in Mycosis Fungoides and Sézary Syndrome exhibit a CD4+/CD7−/CD26− phenotype.

More questions like these – with explanations and spaced repetition – in the app.

Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.